Neuros Medical Announces Successful Pilot Study: Data to Be Presented at International Neuromodulation Society’s World Congress

Neuros Medical Announces Successful Pilot Study: Data to Be Presented at International Neuromodulation Society’s World Congress

<0> Neuros Medical, Inc.Jon J. Snyder, President and CEO440-951-BLOK (2565)440-487-7515 </0>

Neuros Medical, Inc., a medical device company, announced significant results today from their long term pilot study. The study evaluated the Company’s patented on-demand, high frequency Electrical Nerve Block technology which focused on patients afflicted with chronic amputation pain. This debilitating condition affects nearly one million patients in the U.S. alone.

Results indicated that 7 out of 9 study subjects reported significant pain reduction (defined as 50% or greater) observed for up to 12 months of evaluation. The study demonstrated no safety issues over the treatment period. Study subjects reported an average pain score reduction of 6 to 1 (an 83% pain reduction) based on a 0 to 10 Numerical Rating Scale. Significant pain reduction was reported in 91% of all treatment sessions. In addition, more than half of the subjects discontinued their narcotic pain medication use during the study.

The study was led by Dr. Amol Soin of the Kettering Health Network Innovation Center and the Ohio Pain Clinic. “It’s outstanding to see the Neuros technology continue to provide such significant pain relief for patients,” said Dr. Soin. “It’s also very promising to see the safety results confirmed over a larger set of patients for such an extended period of time,” he added.

Jon J. Snyder, President and CEO of Neuros Medical, said, “We are extremely pleased with the opportunity to improve the lives of amputees. Our study results have shown that study subject pain scores are consistently and significantly reduced over this long term evaluation. This provides further clinical evidence of the strong potential of our treatment for patients suffering from chronic pain. We look forward to sharing more details at the upcoming International Neuromodulation Society’s 11 World Congress in Berlin, Germany, June 8-13.”

Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on developing proprietary therapies for unmet needs to patients worldwide. The Company’s patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of conditions including amputation pain, post-surgical pain, migraine, and trigeminal neuralgia.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.